NEW YORK (GenomeWeb News) – Life Technologies and TriCore Reference Laboratories will collaborate to establish TriCore as a regional Next Generation Sequencing Center of Excellence, Life Tech said today.
The agreement is part of Life Tech's initiative to establish a global alliance of centers running next-gen sequencing-based oncology panels for clinical research.
As part of the agreement, TriCore, a not-for-profit medical reference laboratory, will provide Life Tech's next-gen oncology panels, including the Ion AmpliSeq panels that run on the Ion Torrent PGM and Ion Proton sequencing systems, to clinical researchers.
Albuquerque, NM-based TriCore will also work with the pathology department at the University of New Mexico Health Sciences Center.
"This alliance fits with TriCore's commitment to oncology services and will allow us to provide greater value to our clients," Michael Crossey, TriCore's interim CEO and executive medical director, said in a statement. "The results we generate through next-generation sequencing will be used to elucidate new drug targets with the potential to guide therapeutic options more efficiently in the future."